Form 8-K - Current report:
SEC Accession No. 0001367644-17-000003
Filing Date
2017-01-09
Accepted
2017-01-09 08:09:46
Documents
21
Period of Report
2017-01-09
Items
Item 2.02: Results of Operations and Financial Condition
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 form8k_jpm_1_9_17.htm 8-K 19016
2 exhibit99_1.htm EX-99.1 144983
3 JPM SLIDE DECK exhibit99_2.htm EX-99.2 44126
4 exhibit99_2slide1.jpg GRAPHIC 68331
5 exhibit99_2slide2.jpg GRAPHIC 273411
6 exhibit99_2slide3.jpg GRAPHIC 120539
7 exhibit99_2slide4.jpg GRAPHIC 188759
8 exhibit99_2slide5.jpg GRAPHIC 174012
9 exhibit99_2slide6.jpg GRAPHIC 71232
10 exhibit99_2slide7.jpg GRAPHIC 117543
11 exhibit99_2slide8.jpg GRAPHIC 98053
12 exhibit99_2slide9.jpg GRAPHIC 120948
13 exhibit99_2slide10.jpg GRAPHIC 72836
14 exhibit99_2slide11.jpg GRAPHIC 130758
15 exhibit99_2slide12.jpg GRAPHIC 92335
16 exhibit99_2slide13.jpg GRAPHIC 111517
17 exhibit99_2slide14.jpg GRAPHIC 88187
18 exhibit99_2slide15.jpg GRAPHIC 74355
19 exhibit99_2slide16.jpg GRAPHIC 71999
20 exhibit99_2slide17.jpg GRAPHIC 114263
21 exhibit99_2slide18.jpg GRAPHIC 103663
  Complete submission text file 0001367644-17-000003.txt   3093289
Mailing Address 400 PROFESSIONAL DR, SUITE 400 GAITHERSBURG MD 20879
Business Address 400 PROFESSIONAL DR, SUITE 400 GAITHERSBURG MD 20879 240-631-3200
Emergent BioSolutions Inc. (Filer) CIK: 0001367644 (see all company filings)

EIN.: 141902018 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-33137 | Film No.: 17515853
SIC: 2834 Pharmaceutical Preparations